SCHEMBL19744027

SCHEMBL19744027

CCOC(=O)c1cn[c]nc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
ALDH1A1 P00352 4/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
KDM4E B2RXH2 2/20 0.43
RAB9A P51151 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPT P10636 2/20 0.41
NPC1 O15118 1/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
CA14 Q9ULX7 2/20 0.40
ALOX15 P16050 1/20 0.40
HSP90AA1 P07900 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2438523 0.85 TSHR (0.46) TSHRALDH1A1MEN1KMT2AKDM4E
SCHEMBL8627470 0.83 ALDH1A1 (0.50) TSHRALDH1A1MEN1KMT2AKDM4E
SCHEMBL2441803 0.82 TSHR (0.40) TSHRALDH1A1KMT2AKDM4ERAB9A
SCHEMBL2440375 0.81 ALDH1A1 (0.51) TSHRALDH1A1MEN1KMT2ARAB9A
SCHEMBL16446598 0.80 KDM4E (0.57) TSHRALDH1A1MEN1KMT2AKDM4E
SCHEMBL11804105 0.76 SMN1; SMN2 (0.43) ALDH1A1KMT2AKDM4ERAB9ACYP1A2
SCHEMBL15415001 0.75 LMNA (0.44) TSHRALDH1A1MEN1KMT2AKDM4E
SCHEMBL15415100 0.75 KMT2A (0.56) ALDH1A1MEN1KMT2AKDM4ERAB9A
SCHEMBL3453344 0.74 CYP2C9 (0.51) TSHRALDH1A1MEN1KMT2AKDM4E
SCHEMBL15415637 0.72 JAK2 (0.53) TSHRALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311830-B Microbicidal oxadiazole derivatives 先正达参股股份有限公司 2023-02-24 CN disclosed
US-11026427-B2 Microbiocidal oxadiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2021-06-08 US disclosed
US-20190223441-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2019-07-25 US disclosed
EP-3472136-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES Syngenta Participations AG (CH) 2019-04-24 EP disclosed
WO-2017220485-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190223441-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES PRF1, NOX3, NOX1 TSHR 2867/4885ALDH1A1 408/4885MEN1 3645/4885
US-11026427-B2 Microbiocidal oxadiazole derivatives PRF1, NOX3, NOX1 TSHR 2867/4885ALDH1A1 408/4885MEN1 3645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.